Statin use associated with statistically significant reduction in colorectal cancer

Oct 18, 2010

A systematic review of the medical literature supports the hypothesis that statins, cholesterol‐lowering drugs used to prevent cardiac problems, are associated with reduced risk of colon and rectal cancers. A comprehensive analysis by investigators at the University of Michigan at Ann Arbor, included 22 scientific studies with more than 2.5 million combined participants.

"Statin use was associated with a statistically significant reduction in colorectal cancer," explained Jewel Samadder, M.D., MSc. The relative risk was 0.88 (95% CI 0.84‐0.93; n=22) and represents a 12% reduction in the odds of colorectal cancer among statin users. This effect was largely consistent across study design with both case control and cohort studies showing a strong correlation. The length of statin use, both greater than 6 months and greater than 5 years of use was associated with reduction in colorectal cancer risk. Importantly, when the analysis was stratified for statin type, the most common category of statins, lipophilic (which includes atorvastatin or Lipitor), showed the greatest effect.

"Observational studies have suggested that long‐term use of statins is associated with reduced risk of several cancers, including breast, prostate, lung, pancreas and liver. Our findings suggest that randomized controlled trials designed to test the hypothesis that statins reduce the risk of colorectal are warranted," added Dr. Samadder.

Explore further: Study reveals a cause of poorer outcomes for African-American patients with breast cancer

Related Stories

Study shows why statins protect some against cancer

Apr 26, 2010

(PhysOrg.com) -- Weill Cornell researchers report almost half of Caucasians taking statins are probably not protected against cancer as well as other people because of a particular inherited gene variant.

Statins Inhibit Inflammation Within Prostate Tumors

Feb 18, 2010

(PhysOrg.com) -- Patients with prostate cancer who regularly use statins to lower their cholesterol may be enjoying a secondary benefit from the drugs: A new study from Duke University Medical Center shows that statins significantly ...

Study indicates cancer preventive effect for statins

May 05, 2009

The commonly used prescription statin drugs may have a protective effect in the prevention of liver cancer and lead to a reduction in the need for gallbladder removals, according to two studies published in Gastroenterology. As mil ...

Recommended for you

DNA blood test detects lung cancer mutations

Apr 17, 2015

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

Apr 17, 2015

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.